Characteristics | 135 patients |
---|---|
Median age (years) | 39 (31-50) |
Male sex | 123 (91.1) |
Race/ethnicity | Â |
   Taiwanese | 133 (98.5) |
   other Asians | 2 (1.5) |
HIV risk factor | Â |
   Homosexual | 53 (39.3) |
   Bisexual | 7 (5.2) |
   Injecting drug use | 16 (11.9) |
   Transfusion-related | 3 (2.2) |
   Heterosexual/other/unknown | 56 (41.5) |
HIV-related characteristics | Â |
   Newly diagnosed HIV infection | 60 (44.4) |
   Time since HIV diagnosis (month) | 1.23 (0-36) |
   Time since AIDS diagnosis (month) | 0.73 (0-26) |
   Prior HAART at hospital admission | 49 (36.3) |
   Duration of HAART for patients on prior HAART (month)a | 13 (6-48) |
   HAART initiated during ICU stay | 12 (8.9) |
   HAART use in ICU | 82 (60.7) |
   HIV viral load (copies/ml)b | 217,000 (34,500-631,500) |
   CD4 lymphocyte count (cells/mm3)c | 30 (13-103) |
Organ failure status | Â |
   Mechanical ventilator use | 106 (78.5) |
   Shock (use of vasopressors > 24 hours) | 49 (36.3) |
   Renal replacement therapy | 11 (8.1) |
Time from hospitalization to ICU admission (days) | 2 (0-9.0) |
Laboratory data | Â |
   Albumin (g/dL)d | 2.83 (2.40-3.40) |
   LDH (units/L)e | 966.5 (686.5-1446.25) |
APACHE II score | 19 (15-25) |
in-ICU mortality | 50 (37.0) |
in-hospital mortality | 66 (48.9) |